Poseida Therapeutics, Inc. Depreciation
Poseida Therapeutics, Inc. reported Depreciation of $2.60 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2021-03-11
- Poseida Therapeutics, Inc. depreciation for the quarter ending 2020-12-31 was $1.10M, a 175.00% increase year-over-year.
- Poseida Therapeutics, Inc. depreciation for the quarter ending 2020-09-30 was $600.00K, a 100.00% increase year-over-year.
- Poseida Therapeutics, Inc. depreciation for the quarter ending 2019-12-31 was $400.00K.
- Poseida Therapeutics, Inc. depreciation for the quarter ending 2019-09-30 was $300.00K.
- Poseida Therapeutics, Inc. depreciation for fiscal 2020 was $2.60M, a 116.67% increase from fiscal 2019.
- Poseida Therapeutics, Inc. depreciation for fiscal 2019 was $1.20M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.70M derived: sum of 2 quarters · filed 2021-03-11 | $2.60M 10-K · filed 2021-03-11 | |
| 2020-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.50M 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $900.00K 10-Q · filed 2020-08-20 | |||
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $700.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.20M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $800.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $500.00K 10-Q · filed 2020-08-20 |